Drug validation trail underway

The unique fibrosis model offered by InfiCure is attracting international attention. Last month the startup signed their first contract for a full-service preclinical pilot study to test two substances for an american client in Boston. The trial i currently underway, with all lab work beeing done on location in Umeå. […]

Drug validation trail underway2017-02-04T06:19:54+00:00

A new preclinical model

InfiCure Bio, a life-science company in the field of inflammation and fibrosis, has characterized a new preclinical model that spontaneously develops chronic inflammation and fibrosis in multiple organs. The model is called the non-obese diabetic inflammation and fibrosis (N-IF) mouse and you can read all about it here. […]

A new preclinical model2017-02-04T06:24:27+00:00